SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike M who wrote (1440)11/5/1999 11:15:00 PM
From: Mark Marcellus  Read Replies (2) of 5582
 
One thing is pretty certain. AJIC is not likely to publish the second clinical. (That clinical is not yet complete by the way). In fact, the officer I talked to seemed to wonder if the results would be presented to medical journals or simply announced....

No need for peer review or journals eh? Management of this company has such integrity that we can just take them on their word that studies show that Zicam is the greatest thing since COLD-EEZE. And so many people were sure that a journal article was going to be published. I'm just shocked, shocked that it may not happen.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext